Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of
causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ …

Tumor necrosis factor (TNF)-targeted therapies are increasingly used for a rapidly
expanding number of rheumatic and autoimmune diseases. With this use and longer follow-up …

Sjögren syndrome (SjS) is a systemic autoimmune disease that primarily affects the exocrine
glands (mainly the salivary and lacrimal glands) and results in the severe dryness of …

The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in
recent decades: treatment decisions remain challenging in clinical practice, without a specific …

Methods We searched Medline for English language articles published between 1 January
1986 and 31 August 2011 for studies in adult humans using the MeSH term “Sjögren’s …

IgG4-related disease (IgG4-RD) is an emerging immune-mediated disease with the
capability of involving essentially any organ. The epidemiology of this disease has not been …

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-Cov-2
infection, continue to have signs and symptoms not explainable by other causes. The …

Anti-TNF agents are increasingly being used for a rapidly expanding number of rheumatic
and systemic autoimmune diseases. As a result of this use, and of the longer follow-up …

The emergence of tumor necrosis factor-α (TNF-α)-targeted therapies as a key therapeutic
option for patients with rheumatic, digestive, and dermatologic autoimmune diseases has …

OBJECTIVES: To analyze the clinical characteristics, outcomes, and patterns of association
with the different biologic agents used in all reported cases of adult patients developing …